{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:52:01Z","timestamp":1790952721831,"version":"4.1.0"},"reference-count":278,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bone metastases remain a leading cause of morbidity and mortality in patients with advanced breast, prostate, and lung cancers. A striking clinical feature of bone metastasis is the ability of disseminated tumor cells (DTCs) to persist in a dormant state for years or even decades before reawakening to drive overt disease. While the molecular and microenvironmental cues that induce and maintain dormancy have been increasingly studied, the mechanisms governing dormancy escape remain poorly defined yet are critical for preventing relapse. In this review, we synthesize emerging evidence on how the bone microenvironment orchestrates the transition of dormant tumor cells into proliferative lesions. We discuss how osteoclast-mediated bone resorption liberates growth factors such as TGF-\u03b2 and IGF-1, fueling reactivation; how loss of osteoblast-mediated quiescence signals disrupts the endosteal niche; and how bone marrow adipocytes provide metabolic support through lipid transfer and adipokine secretion. We highlight the role of immune surveillance in maintaining dormancy and how immunosuppressive myeloid populations, regulatory T cells, and inflammatory triggers, such as neutrophil extracellular traps, promote escape. Additional emphasis is placed on extracellular matrix remodeling, mechanotransduction, angiogenic switching, and systemic factors, including aging, hormonal changes, and sympathetic nervous system activation. We also review epigenetic and metabolic reprogramming events within dormant cells that enable reactivation. Finally, we evaluate therapeutic strategies to sustain dormancy or prevent reawakening, including osteoclast-targeted therapies, immune-modulating approaches, and epigenetic or metabolic interventions. By integrating these insights, we identify key knowledge gaps and propose future directions to intercept dormancy escape and delay or prevent metastatic relapse in bone.<\/jats:p>","DOI":"10.3390\/ijms262411893","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:20:57Z","timestamp":1765369257000},"page":"11893","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Microenvironmental and Molecular Pathways Driving Dormancy Escape in Bone Metastases"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8614-5718","authenticated-orcid":false,"given":"Mohamad","family":"Bakir","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6963-2878","authenticated-orcid":false,"given":"Alhomam","family":"Dabaliz","sequence":"additional","affiliation":[{"name":"Department of Clinical Skills, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Dawalibi","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences Division, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9708-2111","authenticated-orcid":false,"given":"Khalid S.","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone Metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e4231","DOI":"10.21769\/BioProtoc.4231","article-title":"Measurement of Bone Metastatic Tumor Growth by a Tibial Tumorigenesis Assay","volume":"11","author":"Zhang","year":"2021","journal-title":"Bio Protoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"a037556","DOI":"10.1101\/cshperspect.a037556","article-title":"Cancer Cell Dormancy in Metastasis","volume":"10","author":"Summers","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_4","first-page":"e21589","article-title":"An Atypical Behavior of Metastatic Lung Disease in a Young Woman with Osteosarcoma: A Case Report","volume":"14","author":"Acquisto","year":"2022","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1038\/s41591-025-03877-3","article-title":"Targeting Dormant Tumor Cells to Prevent Recurrent Breast Cancer: A Randomized Phase 2 Trial","volume":"31","author":"DeMichele","year":"2025","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the Bone in Cancer Metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41467-021-21045-2","article-title":"CD39+PD-1+CD8+ T Cells Mediate Metastatic Dormancy in Breast Cancer","volume":"12","author":"Vermeer","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","article-title":"The Adipocyte Microenvironment and Cancer","volume":"41","author":"Mukherjee","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ncb3570","article-title":"Bone Marrow Adipocytes Promote the Regeneration of Stem Cells and Haematopoiesis by Secreting SCF","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The Perivascular Niche Regulates Breast Tumour Dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Verbruggen, S.W., Thompson, C.L., Duffy, M.P., Lunetto, S., Nolan, J., Pearce, O.M.T., Jacobs, C.R., and Knight, M.M. (2021). Mechanical Stimulation Modulates Osteocyte Regulation of Cancer Cell Phenotype. Cancers, 13.","DOI":"10.3390\/cancers13122906"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kreps, L.M., and Addison, C.L. (2021). Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062911"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"218097","DOI":"10.1016\/j.canlet.2025.218097","article-title":"Cancer Dormancy and Metabolism: From Molecular Insights to Translational Opportunities","volume":"635","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Jahanban-Esfahlan, R., Seidi, K., Manjili, M.H., Jahanban-Esfahlan, A., Javaheri, T., and Zare, P. (2019). Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers, 11.","DOI":"10.3390\/cancers11081207"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-24-0030","article-title":"Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy","volume":"84","author":"Bushnell","year":"2024","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2023.01.005","article-title":"Perioperative Escape from Dormancy of Spontaneous Micro-Metastases: A Role for Malignant Secretion of IL-6, IL-8, and VEGF, through Adrenergic and Prostaglandin Signaling","volume":"109","author":"Haldar","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tips.2018.12.004","article-title":"Targeting Cancer Cell Dormancy","volume":"40","author":"Recasens","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Andrzejewski, S., Winter, M., Garcia, L.E., Akinrinmade, O., Marques, F.D.M., Zacharioudakis, E., Skwarska, A., Aguirre-Ghiso, J., Konopleva, M., and Zheng, G. (2025). Quiescent OXPHOS-High Triple-Negative Breast Cancer Cells That Persist after Chemotherapy Depend on BCL-XL for Survival. bioRxiv.","DOI":"10.1101\/2025.08.21.671546"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11914-019-00532-y","article-title":"Breast Cancer Dormancy in Bone","volume":"17","author":"Clements","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_20","first-page":"e1156","article-title":"Tumor Dormancy in Bone","volume":"3","author":"Mayhew","year":"2020","journal-title":"Cancer Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2021.09.037","article-title":"Prostate Cancer Dormancy and Recurrence","volume":"524","author":"Cackowski","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wieder, R. (2022). Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone Marrow. Cancers, 14.","DOI":"10.3390\/cancers14143344"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/cas.13917","article-title":"Dormancy in Cancer","volume":"110","author":"Endo","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14740\/wjon1419","article-title":"Tumor Dormancy: Biologic and Therapeutic Implications","volume":"13","author":"Balayan","year":"2022","journal-title":"World J. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI42002","article-title":"Tumor Cells Disseminate Early, but Immunosurveillance Limits Metastatic Outgrowth, in a Mouse Model of Melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4143\/crt.2023.468","article-title":"Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies","volume":"55","author":"Min","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1083\/jcb.147.1.89","article-title":"Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling","volume":"147","author":"Kovalski","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1091\/mbc.12.4.863","article-title":"Urokinase Receptor and Fibronectin Regulate the ERK(MAPK) to P38(MAPK) Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy in Vivo","volume":"12","author":"Liu","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for Cancer Therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100621","DOI":"10.1016\/j.jbo.2024.100621","article-title":"Bone Niches in the Regulation of Tumour Cell Dormancy","volume":"47","author":"Smith","year":"2024","journal-title":"J. Bone Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1541-7786.MCR-17-0132","article-title":"Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow","volume":"15","author":"Decker","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","article-title":"Osteoblast-Osteoclast Interactions","volume":"59","author":"Chen","year":"2018","journal-title":"Connect. Tissue Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone Metastasis: Mechanisms, Therapies, and Biomarkers","volume":"101","author":"Coleman","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e00597","DOI":"10.1002\/advs.202500597","article-title":"QSOX2-Mediated Disulfide Bond Modification Enhances Tumor Stemness and Chemoresistance by Activating TSC2\/mTOR\/c-Myc Feedback Loop in Esophageal Squamous Cell Carcinoma","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts Control Reactivation of Dormant Myeloma Cells by Remodelling the Endosteal Niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10585-022-10176-5","article-title":"Review Old Bone, New Tricks","volume":"39","author":"Barsky","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100597","DOI":"10.1016\/j.jbo.2024.100597","article-title":"The Osteoblast in Regulation of Tumor Cell Dormancy and Bone Metastasis","volume":"45","author":"Zarrer","year":"2024","journal-title":"J. Bone Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0501-y","article-title":"Notch2 Pathway Mediates Breast Cancer Cellular Dormancy and Mobilisation in Bone and Contributes to Haematopoietic Stem Cell Mimicry","volume":"121","author":"Capulli","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1084\/jem.20180661","article-title":"Wnt5a Induces and Maintains Prostate Cancer Cells Dormancy in Bone","volume":"216","author":"Ren","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e70030","DOI":"10.1002\/mco2.70030","article-title":"Sarcopenia and Cachexia: Molecular Mechanisms and Therapeutic Interventions","volume":"6","author":"Wang","year":"2025","journal-title":"MedComm (2020)"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, Z., Ngandiri, D.A., Llerins Perez, M., Wolf, A., and Wang, Y. (2022). The Molecular Brakes of Adipose Tissue Lipolysis. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.826314"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Maroni, P. (2020). Leptin, Adiponectin, and Sam68 in Bone Metastasis from Breast Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031051"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1002\/jcp.26884","article-title":"Adipokines, Adiposity, and Bone Marrow Adipocytes: Dangerous Accomplices in Multiple Myeloma","volume":"233","author":"Morris","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/01635581.2020.1792946","article-title":"Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway","volume":"73","author":"Gorrab","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12967-022-03283-0","article-title":"Adiponectin Suppresses Tumor Growth of Nasopharyngeal Carcinoma through Activating AMPK Signaling Pathway","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Nigro, E., Daniele, A., Salzillo, A., Ragone, A., Naviglio, S., and Sapio, L. (2021). AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115569"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jbmr.3951","article-title":"Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha","volume":"35","author":"Morris","year":"2020","journal-title":"J. Bone Min. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"188419","DOI":"10.1016\/j.bbcan.2020.188419","article-title":"Resistin: An Inflammatory Cytokine with Multi-Faceted Roles in Cancer","volume":"1874","author":"Sudan","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Muruganandan, S., Ionescu, A.M., and Sinal, C.J. (2020). At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072277"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1158\/1538-7445.AM2020-2646","article-title":"Abstract 2646: CD39+PD-1+CD8+ T Cells Mediate Metastatic Dormancy in Breast Cancer","volume":"80","author":"Cuadrado","year":"2020","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","article-title":"Hepatic Stellate Cells Suppress NK Cell-Sustained Breast Cancer Dormancy","volume":"594","author":"Correia","year":"2021","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"SY31-02","DOI":"10.1158\/1538-7445.AM2022-SY31-02","article-title":"Abstract SY31-02: Revisiting NK Cell Immunity to Prevent Metastasis","volume":"82","author":"Correia","year":"2022","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"PO005","DOI":"10.1158\/1538-7445.TME21-PO005","article-title":"Abstract PO005: Hepatic Stellate Cells Suppress NK Cell Sustained Breast Cancer Dormancy","volume":"81","author":"Correia","year":"2021","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Haist, M., Stege, H., Grabbe, S., and Bros, M. (2021). The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment. Cancers, 13.","DOI":"10.3390\/cancers13020210"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mota Reyes, C., Demir, E., \u00c7ifciba\u015f\u0131, K., Istvanffy, R., Friess, H., and Demir, I.E. (2022). Regulatory T Cells in Pancreatic Cancer: Of Mice and Men. Cancers, 14.","DOI":"10.3390\/cancers14194582"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2502597122","DOI":"10.1073\/pnas.2502597122","article-title":"Tumor Immune Evasion: Systemic Immunosuppressive Networks beyond the Local Microenvironment","volume":"122","author":"Yan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan Metabolism as a Common Therapeutic Target in Cancer, Neurodegeneration and Beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Siret, C., Collignon, A., Silvy, F., Robert, S., Cheyrol, T., Andr\u00e9, P., Rigot, V., Iovanna, J., Van De Pavert, S., and Lombardo, D. (2020). Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.03070"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Yang, Y., Li, C., Liu, T., Dai, X., and Bazhin, A.V. (2020). Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01371"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Goldmann, O., Nwofor, O.V., Chen, Q., and Medina, E. (2024). Mechanisms Underlying Immunosuppression by Regulatory Cells. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1328193"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gao, X., Sui, H., Zhao, S., Gao, X., Su, Y., and Qu, P. (2021). Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.585214"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"112922","DOI":"10.1016\/j.intimp.2024.112922","article-title":"Immunosuppressive MDSC and Treg Signatures Predict Prognosis and Therapeutic Response in Glioma","volume":"141","author":"Yin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wen, Y., Zhu, Y., Zhang, C., Yang, X., Gao, Y., Li, M., Yang, H., Liu, T., and Tang, H. (2022). Chronic Inflammation, Cancer Development and Immunotherapy. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1040163"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bai, R., Chen, N., Li, L., Du, N., Bai, L., Lv, Z., Tian, H., and Cui, J. (2020). Mechanisms of Cancer Resistance to Immunotherapy. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01290"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, S., Chen, W., Xu, T., Li, J., Yu, J., He, Y., and Qiu, S. (2025). The Impact of Aberrant Lipid Metabolism on the Immune Microenvironment of Gastric Cancer: A Mini Review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1639823"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154711","DOI":"10.1016\/j.prp.2023.154711","article-title":"Myeloid-Derived Suppressor Cells: Key Immunosuppressive Regulators and Therapeutic Targets in Cancer","volume":"248","author":"Li","year":"2023","journal-title":"Pathol.-Res. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"De Cicco, P., Ercolano, G., and Ianaro, A. (2020). The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01680"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Andr\u00e9s, C., P\u00e9rez De La Lastra, J., Juan, C., Plou, F., and P\u00e9rez-Lebe\u00f1a, E. (2023). Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress. Vaccines, 11.","DOI":"10.3390\/vaccines11020218"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-Derived Suppressor Cells as Immunosuppressive Regulators and Therapeutic Targets in Cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-018-0081-8","article-title":"NETs Awaken Sleeping Cancer Cells","volume":"18","author":"Bordon","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Demkow, U. (2021). Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis. Cancers, 13.","DOI":"10.3390\/cancers13174495"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1002\/mco2.647","article-title":"Neutrophil Extracellular Traps in Cancer","volume":"5","author":"Ma","year":"2024","journal-title":"MedComm"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2301343","DOI":"10.1002\/adhm.202301343","article-title":"Bacterial Magnetosome-Hitchhiked Quick-Frozen Neutrophils for Targeted Destruction of Pre-Metastatic Niche and Prevention of Tumor Metastasis","volume":"12","author":"Han","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12672-025-03451-w","article-title":"Neutrophil Extracellular Traps in Tumor Metastasis: Mechanisms, and Therapeutic Implications","volume":"16","author":"Li","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5599660","DOI":"10.1155\/2023\/5599660","article-title":"Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy","volume":"2023","author":"Zuo","year":"2023","journal-title":"J. Immunol. Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Masucci, M.T., Minopoli, M., Del Vecchio, S., and Carriero, M.V. (2020). The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01749"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7022337","DOI":"10.1155\/2023\/7022337","article-title":"The Formation of NETs and Their Mechanism of Promoting Tumor Metastasis","volume":"2023","author":"Li","year":"2023","journal-title":"J. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mortaz, E., Alipoor, S.D., Adcock, I.M., Mumby, S., and Koenderman, L. (2018). Update on Neutrophil Function in Severe Inflammation. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02171"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40164-022-00345-3","article-title":"The Role of Neutrophil Extracellular Traps in Cancer Progression, Metastasis and Therapy","volume":"11","author":"Chen","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41368-023-00236-1","article-title":"Carcinoma-Associated Fibroblast-Derived Lysyl Oxidase-Rich Extracellular Vesicles Mediate Collagen Crosslinking and Promote Epithelial-Mesenchymal Transition via p-FAK\/p-Paxillin\/YAP Signaling","volume":"15","author":"Liu","year":"2023","journal-title":"Int. J. Oral Sci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Di Martino, J.S., Akhter, T., and Bravo-Cordero, J.J. (2021). Remodeling the ECM: Implications for Metastasis and Tumor Dormancy. Cancers, 13.","DOI":"10.3390\/cancers13194916"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Paolillo, M., and Schinelli, S. (2019). Extracellular Matrix Alterations in Metastatic Processes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194947"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of Extracellular Matrix Remodelling in Tumour Progression and Metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Qi, Y., and Xu, R. (2018). Roles of PLODs in Collagen Synthesis and Cancer Progression. Front. Cell Dev. Biol., 6.","DOI":"10.3389\/fcell.2018.00066"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","article-title":"A Tumor-Derived Type III Collagen-Rich ECM Niche Regulates Tumor Cell Dormancy","volume":"3","author":"Nobre","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-22-2034","article-title":"Collagens in Cancer: Structural Regulators and Guardians of Cancer Progression","volume":"83","year":"2023","journal-title":"Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"eaaz4157","DOI":"10.1126\/sciadv.aaz4157","article-title":"Tumor Cell\u2013Organized Fibronectin Maintenance of a Dormant Breast Cancer Population","volume":"6","author":"Barney","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ejca.2010.02.027","article-title":"Extracellular Matrix: A Gatekeeper in the Transition from Dormancy to Metastatic Growth","volume":"46","author":"Barkan","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Libring, S., Shinde, A., Chanda, M.K., Nuru, M., George, H., Saleh, A.M., Abdullah, A., Kinzer-Ursem, T.L., Calve, S., and Wendt, M.K. (2020). The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites. Cancers, 12.","DOI":"10.3390\/cancers12051270"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.05.002","article-title":"Intrafibrillar, Bone-Mimetic Collagen Mineralization Regulates Breast Cancer Cell Adhesion and Migration","volume":"198","author":"Choi","year":"2019","journal-title":"Biomaterials"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12967-022-03768-y","article-title":"Biological Role of Matrix Stiffness in Tumor Growth and Treatment","volume":"20","author":"Deng","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","article-title":"Targeting Extracellular Matrix Stiffness and Mechanotransducers to Improve Cancer Therapy","volume":"15","author":"Jiang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12935-023-02992-w","article-title":"Tumor Matrix Stiffness Provides Fertile Soil for Cancer Stem Cells","volume":"23","author":"Safaei","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Wang, Z., Wang, W., Luo, Q., and Song, G. (2025). High Matrix Stiffness Accelerates Migration of Hepatocellular Carcinoma Cells through the Integrin \u03921-Plectin-F-Actin Axis. BMC Biol., 23.","DOI":"10.1186\/s12915-025-02113-1"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every Step of the Way: Integrins in Cancer Progression and Metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ishihara, S., and Haga, H. (2022). Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors. Cancers, 14.","DOI":"10.3390\/cancers14041049"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2018.10.015","article-title":"Untangling the Response of Bone Tumor Cells and Bone Forming Cells to Matrix Stiffness and Adhesion Ligand Density by Means of Hydrogels","volume":"188","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10555-023-10094-2","article-title":"Regulation of Dormancy during Tumor Dissemination: The Role of the ECM","volume":"42","author":"Mukherjee","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e2111046118","DOI":"10.1073\/pnas.2111046118","article-title":"Microenvironment-Mediated Cancer Dormancy: Insights from Metastability Theory","volume":"119","author":"Bakhshandeh","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s43018-021-00179-8","article-title":"Bone Marrow NG2+\/Nestin+ Mesenchymal Stem Cells Drive DTC Dormancy via TGF-\u03922","volume":"2","author":"Nobre","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.acr.2016.07.002","article-title":"The Relationship Between Dormant Cancer Cells and Their Microenvironment","volume":"132","author":"Linde","year":"2016","journal-title":"Advances in Cancer Research"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Sistigu, A., Musella, M., Galassi, C., Vitale, I., and De Maria, R. (2020). Tuning Cancer Fate: Tumor Microenvironment\u2019s Role in Cancer Stem Cell Quiescence and Reawakening. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02166"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ahad, A., Leng, F., Ichise, H., Schrom, E., So, J.Y., Sellner, C., Gu, Y., Wang, W., Kieu, C., and Park, W.Y. (2025). Immune Niche Formation in Engineered Mouse Models Reveals Mechanisms of Tumor Dormancy. bioRxiv.","DOI":"10.1101\/2025.04.16.649000"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","article-title":"Osteoblasts and Osteoclasts: An Important Switch of Tumour Cell Dormancy during Bone Metastasis","volume":"41","author":"Dai","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e10125","DOI":"10.1002\/jbm4.10125","article-title":"Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities","volume":"3","author":"Byrne","year":"2019","journal-title":"JBMR Plus"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Russo, S., Scotto Di Carlo, F., and Gianfrancesco, F. (2022). The Osteoclast Traces the Route to Bone Tumors and Metastases. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.886305"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Liang, J., Liu, P., Wang, Q., Liu, L., and Zhao, H. (2022). The RANK\/RANKL\/OPG System and Tumor Bone Metastasis: Potential Mechanisms and Therapeutic Strategies. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1063815"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e157917","DOI":"10.1172\/JCI157917","article-title":"IL-20RB Mediates Tumoral Response to Osteoclastic Niches and Promotes Bone Metastasis of Lung Cancer","volume":"132","author":"He","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"105662","DOI":"10.1016\/j.jmbbm.2023.105662","article-title":"Mechanoregulation May Drive Osteolysis during Bone Metastasis: A Finite Element Analysis of the Mechanical Environment within Bone Tissue during Bone Metastasis and Osteolytic Resorption","volume":"138","author":"Verbruggen","year":"2023","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1158\/0008-5472.CAN-14-2493","article-title":"Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases","volume":"75","author":"Sottnik","year":"2015","journal-title":"Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semcancer.2019.05.017","article-title":"Mechanical Stress-Induced Autophagic Response: A Cancer-Enabling Characteristic? Semin","volume":"66","author":"Das","year":"2020","journal-title":"Cancer Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","article-title":"Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGF\u03b2RIII\u2013p38MAPK\u2013pS249\/T252RB Pathway","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone Metastasis: The Importance of the Neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"109293","DOI":"10.1016\/j.celrep.2021.109293","article-title":"Breast Tumor Stiffness Instructs Bone Metastasis via Maintenance of Mechanical Conditioning","volume":"35","author":"Watson","year":"2021","journal-title":"Cell Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-023-00656-5","article-title":"Linking Cell Mechanical Memory and Cancer Metastasis","volume":"24","author":"Cambria","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2201663","DOI":"10.1002\/advs.202201663","article-title":"Deleterious Mechanical Deformation Selects Mechanoresilient Cancer Cells with Enhanced Proliferation and Chemoresistance","volume":"10","author":"Jiang","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbo.2016.04.003","article-title":"Vascular Niches for Disseminated Tumour Cells in Bone","volume":"5","author":"Kusumbe","year":"2016","journal-title":"J. Bone Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"340ra73","DOI":"10.1126\/scitranslmed.aad4059","article-title":"Dormant Breast Cancer Micrometastases Reside in Specific Bone Marrow Niches That Regulate Their Transit to and from Bone","volume":"8","author":"Price","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/s41467-021-26556-6","article-title":"Mammary Tumour Cells Remodel the Bone Marrow Vascular Microenvironment to Support Metastasis","volume":"12","author":"Yip","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Magar, A.G., Morya, V.K., Kwak, M.K., Oh, J.U., and Noh, K.C. (2024). A Molecular Perspective on HIF-1\u03b1 and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063313"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s12276-024-01180-8","article-title":"Hypoxia, Oxidative Stress, and the Interplay of HIFs and NRF2 Signaling in Cancer","volume":"56","author":"Bae","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2020.05.026","article-title":"Hypoxia-Mediated Changes in Bone Marrow Microenvironment in Breast Cancer Dormancy","volume":"488","author":"Ferrer","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","article-title":"HIF-1\u03b1 Signaling: Essential Roles in Tumorigenesis and Implications in Targeted Therapies","volume":"11","author":"Zhao","year":"2024","journal-title":"Genes Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1111\/febs.16110","article-title":"Regulation of Redox Signaling in HIF-1-dependent Tumor Angiogenesis","volume":"289","author":"Manuelli","year":"2022","journal-title":"FEBS J."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Musleh Ud Din, S., Streit, S.G., Huynh, B.T., Hana, C., Abraham, A.-N., and Hussein, A. (2024). Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042060"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2407223","DOI":"10.1155\/2022\/2407223","article-title":"Regulation of Transactivation at C-TAD Domain of HIF-1 \u03b1 by Factor-Inhibiting HIF-1 \u03b1 (FIH-1): A Potential Target for Therapeutic Intervention in Cancer","volume":"2022","author":"Rani","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"E992","DOI":"10.1073\/pnas.1718009115","article-title":"HIF Signaling in Osteoblast-Lineage Cells Promotes Systemic Breast Cancer Growth and Metastasis in Mice","volume":"115","author":"Devignes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41556-019-0309-2","article-title":"Bone Vascular Niche E-Selectin Induces Mesenchymal\u2013Epithelial Transition and Wnt Activation in Cancer Cells to Promote Bone Metastasis","volume":"21","author":"Esposito","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/leu.2013.24","article-title":"Hypoxia-Inducible Factor (HIF)-1\u03b1 Suppression in Myeloma Cells Blocks Tumoral Growth in Vivo Inhibiting Angiogenesis and Bone Destruction","volume":"27","author":"Storti","year":"2013","journal-title":"Leukemia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil Extracellular Traps Produced during Inflammation Awaken Dormant Cancer Cells in Mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Yang, H., Biermann, M.H., Brauner, J.M., Liu, Y., Zhao, Y., and Herrmann, M. (2016). New Insights into Neutrophil Extracellular Traps: Mechanisms of Formation and Role in Inflammation. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00302"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.15210","article-title":"The Importance of Inflammation-Induced NETS","volume":"19","author":"Alegre","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Poto, R., Cristinziano, L., Modestino, L., De Paulis, A., Marone, G., Loffredo, S., Galdiero, M.R., and Varricchi, G. (2022). Neutrophil Extracellular Traps, Angiogenesis and Cancer. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020431"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"SY38-01","DOI":"10.1158\/1538-7445.AM2018-SY38-01","article-title":"Abstract SY38-01: Inflammation-Induced Neutrophil Extracellular Traps (NETs) Awaken Dormant Cancer in the Lung Microenvironment","volume":"78","author":"Egeblad","year":"2018","journal-title":"Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Marie, J.C., and Bonnelye, E. (2022). Effects of Estrogens on Osteoimmunology: A Role in Bone Metastasis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.899104"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Hsu, S.-H., Chen, L.-R., and Chen, K.-H. (2024). Primary Osteoporosis Induced by Androgen and Estrogen Deficiency: The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212139"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"5793712","DOI":"10.1152\/physiol.2023.38.S1.5793712","article-title":"Unraveling the Role of Estrogen Signaling in the Breast Cancer-Bone Connection","volume":"38","author":"Funk","year":"2023","journal-title":"Physiology"},{"key":"ref_139","unstructured":"Heshmati, H.M. (2022). Cellular Senescence in Bone. Physiology, IntechOpen."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"bqae038","DOI":"10.1210\/endocr\/bqae038","article-title":"Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice","volume":"165","author":"Cheng","year":"2024","journal-title":"Endocrinology"},{"key":"ref_141","first-page":"386","article-title":"Salute ossea in corso di trattamento adiuvante anti-ormonale nella patologia oncologica: Rischio fratturativo e temporizzazione della terapia","volume":"23","author":"Pisarro","year":"2022","journal-title":"L\u2019Endocrinologo"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13058-022-01576-2","article-title":"The Bone\u2013Muscle Connection in Breast Cancer: Implications and Therapeutic Strategies to Preserve Musculoskeletal Health","volume":"24","author":"Ballinger","year":"2022","journal-title":"Breast Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"100317","DOI":"10.1016\/j.jbo.2020.100317","article-title":"Oestrogen and Zoledronic Acid Driven Changes to the Bone and Immune Environments: Potential Mechanisms Underlying the Differential Anti-Tumour Effects of Zoledronic Acid in Pre- and Post-Menopausal Conditions","volume":"25","author":"George","year":"2020","journal-title":"J. Bone Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Concei\u00e7\u00e3o, F., Sousa, D.M., Tojal, S., Louren\u00e7o, C., Carvalho-Maia, C., Estev\u00e3o-Pereira, H., Lobo, J., Couto, M., Rosenkilde, M.M., and Jer\u00f3nimo, C. (2023). The Secretome of Parental and Bone Metastatic Breast Cancer Elicits Distinct Effects in Human Osteoclast Activity after Activation of \u03922 Adrenergic Signaling. Biomolecules, 13.","DOI":"10.3390\/biom13040622"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Zhang, W., Liu, Y., Xu, J., Fan, C., Zhang, B., Feng, P., Wang, Y., and Kong, Q. (2022). The Role of Sympathetic Nerves in Osteoporosis: A Narrative Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010033"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1538-7445.AM2022-2191","article-title":"Abstract 2191: Alteration of Anti-Tumoral Immunity in the Pre-Metastatic Bone Microenvironment via Autonomic Nerve System Dysfunction","volume":"82","author":"Lee","year":"2022","journal-title":"Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"100219","DOI":"10.1016\/j.mtbio.2022.100219","article-title":"A Metastasis-on-a-Chip Approach to Explore the Sympathetic Modulation of Breast Cancer Bone Metastasis","volume":"13","author":"Sousa","year":"2022","journal-title":"Mater. Today Bio"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Maurizi, A., and Rucci, N. (2018). The Osteoclast in Bone Metastasis: Player and Target. Cancers, 10.","DOI":"10.3390\/cancers10070218"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, H., Chen, T., Qiu, G., and Han, Y. (2024). The Emerging Role of Osteoclasts in the Treatment of Bone Metastases: Rationale and Recent Clinical Evidence. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1445025"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/bonekey.2015.61","article-title":"Chronic Stress, Sympathetic Activation and Skeletal Metastasis of Breast Cancer Cells","volume":"4","author":"Elefteriou","year":"2015","journal-title":"BoneKEy Rep."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Elefteriou, F., Campbell, P.J., and Madel, M.-B. (2023). Autonomic Innervation of the Skeleton. Primer on the Autonomic Nervous System, Elsevier.","DOI":"10.1016\/B978-0-323-85492-4.00063-6"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00109-015-1329-4","article-title":"Bone Metastasis and the Metastatic Niche","volume":"93","author":"Ren","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1186\/s12967-025-06657-2","article-title":"Sympathetic Nervous System in Tumor Progression and Metabolic Regulation: Mechanisms and Clinical Potential","volume":"23","author":"Sun","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Madel, M.-B., and Elefteriou, F. (2021). Mechanisms Supporting the Use of Beta-Blockers for the Management of Breast Cancer Bone Metastasis. Cancers, 13.","DOI":"10.3390\/cancers13122887"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41413-021-00137-1","article-title":"Sympathetic Activity in Breast Cancer and Metastasis: Partners in Crime","volume":"9","author":"Sousa","year":"2021","journal-title":"Bone Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2284486","DOI":"10.1080\/2162402X.2023.2284486","article-title":"Trial Watch: Beta-Blockers in Cancer Therapy","volume":"12","author":"Kepp","year":"2023","journal-title":"Oncoimmunology"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Zhang, F., Wang, Y., Liu, F., Li, Y., Liu, X., Ren, X., and Yuan, X. (2025). Impact of Beta Blockers on Cancer Neuroimmunology: A Systematic Review and Meta-Analysis of Survival Outcomes and Immune Modulation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1635331"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"10702","DOI":"10.1038\/s41598-025-93205-z","article-title":"Beta-Adrenergic Receptor Blockers Improve Survival in Patients with Advanced Non-Small Cell Lung Cancer Combined with Hypertension Undergoing Radiotherapy","volume":"15","author":"Liang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Sharma, A.E., Chan, S., Komorowski, A.S., Cao, X., Gao, Y., Kshatri, K., Desai, K., Kuksis, M., Rosen, M., and Sachdeva, A. (2025). The Impact of Beta Blockers on Survival in Cancer Patients: A Systematic Review and Meta-Analysis. Cancers, 17.","DOI":"10.3390\/cancers17081357"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Katsarelias, D., Eriksson, H., Mikiver, R., Krakowski, I., Nilsson, J.A., Ny, L., and Olofsson Bagge, R. (2020). The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma\u2014A Nation-Wide Swedish Population-Based Retrospective Register Study. Cancers, 12.","DOI":"10.3390\/cancers12113228"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00432-025-06262-2","article-title":"Does Propranolol Have a Role in Cancer Treatment? A Systematic Review of the Epidemiological and Clinical Trial Literature on Beta-Blockers","volume":"151","author":"Tarantola","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"100524","DOI":"10.1016\/j.jbo.2024.100524","article-title":"Epigenetic Control of the Vicious Cycle","volume":"44","author":"Searcy","year":"2024","journal-title":"J. Bone Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Rajan, P.K., Udoh, U.-A., Sanabria, J.D., Banerjee, M., Smith, G., Schade, M.S., Sanabria, J., Sodhi, K., Pierre, S., and Xie, Z. (2020). The Role of Histone Acetylation-\/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238894"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13148-018-0605-x","article-title":"Elevated H3K27me3 Levels Sensitize Osteosarcoma to Cisplatin","volume":"11","author":"He","year":"2019","journal-title":"Clin. Epigenet."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12964-024-01512-1","article-title":"Revealing Role of Epigenetic Modifiers and DNA Oxidation in Cell-Autonomous Regulation of Cancer Stem Cells","volume":"22","author":"Sinha","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Neophytou, C.M., Kyriakou, T.-C., and Papageorgis, P. (2019). Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246158"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11914-021-00670-2","article-title":"Targeting Histone Modifications in Bone and Lung Metastatic Cancers","volume":"19","author":"Edwards","year":"2021","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijbiomac.2020.12.173","article-title":"Histone Acetyl Transferases and Their Epigenetic Impact on Bone Remodeling","volume":"170","author":"Gomathi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12015-024-10807-2","article-title":"Unlocking the Epigenetic Symphony: Histone Acetylation Orchestration in Bone Remodeling and Diseases","volume":"21","author":"Cai","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcdb.2022.11.002","article-title":"Epigenetic Regulation of Bone Remodeling and Bone Metastasis","volume":"154","author":"Sharma","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Tigu, A.B., Ivancuta, A., Uhl, A., Sabo, A.C., Nistor, M., Mure\u0219an, X.-M., Cenariu, D., Timis, T., Diculescu, D., and Gulei, D. (2025). Epigenetic Therapies in Melanoma\u2014Targeting DNA Methylation and Histone Modification. Biomedicines, 13.","DOI":"10.3390\/biomedicines13051188"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1038\/s41467-023-42093-w","article-title":"Positive Regulation of Oxidative Phosphorylation by Nuclear Myosin 1 Protects Cells from Metabolic Reprogramming and Tumorigenesis in Mice","volume":"14","author":"Venit","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"216705","DOI":"10.1016\/j.canlet.2024.216705","article-title":"Cancer Resistance and Metastasis Are Maintained through Oxidative Phosphorylation","volume":"587","author":"Uslu","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic Reprogramming and Epigenetic Modifications on the Path to Cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/febs.14090","article-title":"Metabolic Reprogramming and Epithelial-to-mesenchymal Transition in Cancer","volume":"284","author":"Sciacovelli","year":"2017","journal-title":"FEBS J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"e182330","DOI":"10.1172\/jci.insight.182330","article-title":"HIF1 Activation Safeguards Cortical Bone Formation against Impaired Oxidative Phosphorylation","volume":"9","author":"Khan","year":"2024","journal-title":"JCI Insight"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Li, J., Eu, J.Q., Kong, L.R., Wang, L., Lim, Y.C., Goh, B.C., and Wong, A.L.A. (2020). Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy. Molecules, 25.","DOI":"10.3390\/molecules25204831"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s13402-023-00801-0","article-title":"Crosstalk between Oxidative Phosphorylation and Immune Escape in Cancer: A New Concept of Therapeutic Targets Selection","volume":"46","author":"Qiu","year":"2023","journal-title":"Cell Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41416-022-01869-5","article-title":"Recent Insights into the Effects of Metabolism on Breast Cancer Cell Dormancy","volume":"127","author":"Bartlome","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","article-title":"Emerging Roles of Lipid Metabolism in Cancer Metastasis","volume":"16","author":"Luo","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"217076","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic Reprogramming in Tumor Immune Microenvironment: Impact on Immune Cell Function and Therapeutic Implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation","volume":"77","author":"Yu","year":"2017","journal-title":"Cancer Res."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Moldogazieva, N.T., Mokhosoev, I.M., and Terentiev, A.A. (2020). Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK. Cancers, 12.","DOI":"10.3390\/cancers12040862"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10555-022-10075-x","article-title":"Liquid Biopsy for Monitoring of Tumor Dormancy and Early Detection of Disease Recurrence in Solid Tumors","volume":"42","author":"Heidrich","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Wu, R., Roy, A., Tokumaru, Y., Gandhi, S., Asaoka, M., Oshi, M., Yan, L., Ishikawa, T., and Takabe, K. (2022). NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation. Cancers, 14.","DOI":"10.3390\/cancers14122962"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Drescher, F., Ju\u00e1rez, P., Arellano, D.L., Seraf\u00edn-Higuera, N., Olvera-Rodriguez, F., Jim\u00e9nez, S., Licea-Navarro, A.F., and Fournier, P.G.J. (2020). TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases. Cancers, 12.","DOI":"10.3390\/cancers12040868"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e50162","DOI":"10.15252\/embr.202050162","article-title":"Prostate Cancer Cell-intrinsic Interferon Signaling Regulates Dormancy and Metastatic Outgrowth in Bone","volume":"21","author":"Owen","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13046-023-02849-0","article-title":"Tumor Removal Limits Prostate Cancer Cell Dissemination in Bone and Osteoblasts Induce Cancer Cell Dormancy through Focal Adhesion Kinase","volume":"42","author":"Liu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Singh, D.K., Patel, V.G., Oh, W.K., and Aguirre-Ghiso, J.A. (2021). Prostate Cancer Dormancy and Reactivation in Bone Marrow. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122648"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"eade3186","DOI":"10.1126\/sciadv.ade3186","article-title":"Dynamic Bioinspired Coculture Model for Probing ER+ Breast Cancer Dormancy in the Bone Marrow Niche","volume":"9","author":"Pradhan","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"bqae022","DOI":"10.1210\/endocr\/bqae022","article-title":"Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection","volume":"165","author":"Bae","year":"2024","journal-title":"Endocrinology"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"eado3473","DOI":"10.1126\/scisignal.ado3473","article-title":"Re-Epithelialization of Cancer Cells Increases Autophagy and DNA Damage: Implications for Breast Cancer Dormancy and Relapse","volume":"18","author":"Giri","year":"2025","journal-title":"Sci. Signal."},{"key":"ref_193","first-page":"7","article-title":"Tumor Dormancy and Relapse: Understanding the Molecular Mechanisms of Cancer Recurrence","volume":"12","author":"Tufail","year":"2025","journal-title":"Mil. Med. Res."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Sui, L., Wang, J., Jiang, W.G., Song, X., and Ye, L. (2024). Molecular Mechanism of Bone Metastasis in Breast Cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1401113"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/path.5292","article-title":"From Latency to Overt Bone Metastasis in Breast Cancer: Potential for Treatment and Prevention","volume":"249","author":"Salvador","year":"2019","journal-title":"J. Pathol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Ban, J., Fock, V., Aryee, D.N.T., and Kovar, H. (2021). Mechanisms, Diagnosis and Treatment of Bone Metastases. Cells, 10.","DOI":"10.3390\/cells10112944"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Chen, S., Lei, J., Mou, H., Zhang, W., Jin, L., Lu, S., Yinwang, E., Xue, Y., Shao, Z., and Chen, T. (2024). Multiple Influence of Immune Cells in the Bone Metastatic Cancer Microenvironment on Tumors. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1335366"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular Mechanisms and Clinical Management of Cancer Bone Metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Ring, A., Spataro, M., Wicki, A., and Aceto, N. (2022). Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.929893"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molonc.2016.09.009","article-title":"Tumor Cell Dormancy","volume":"11","author":"Gomis","year":"2017","journal-title":"Mol. Oncol."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Quayle, L.A., Spicer, A., Ottewell, P.D., and Holen, I. (2021). Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy. Cancers, 13.","DOI":"10.3390\/cancers13163922"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41416-023-02401-z","article-title":"A Cell Cycle Centric View of Tumour Dormancy","volume":"129","author":"Weston","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.18632\/oncotarget.2480","article-title":"Characterization of Single Disseminated Prostate Cancer Cells Reveals Tumor Cell Heterogeneity and Identifies Dormancy Associated Pathways","volume":"5","author":"Lam","year":"2014","journal-title":"Oncotarget"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"A013","DOI":"10.1158\/1538-7445.TUMBODY-A013","article-title":"Abstract A013: Microenvironment Driven Dynamic Deposition of Histone H3.3 Controls Entry and Exit from Dormancy in Disseminated Cancer Cells","volume":"84","author":"Drapela","year":"2024","journal-title":"Cancer Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s43018-021-00297-3","article-title":"Astrocytic Laminin-211 Drives Disseminated Breast Tumor Cell Dormancy in Brain","volume":"3","author":"Dai","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s43018-020-0088-5","article-title":"The Current Paradigm and Challenges Ahead for the Dormancy of Disseminated Tumor Cells","volume":"1","author":"Risson","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Dianat-Moghadam, H., Azizi, M., Eslami-S, Z., Cort\u00e9s-Hern\u00e1ndez, L.E., Heidarifard, M., Nouri, M., and Alix-Panabi\u00e8res, C. (2020). The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance. Cancers, 12.","DOI":"10.3390\/cancers12040867"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Boral, D., Liu, H.N., Kenney, S.R., and Marchetti, D. (2020). Molecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer. Cancers, 12.","DOI":"10.3390\/cancers12061626"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Lu, J., Hu, D., Zhang, Y., Ma, C., Shen, L., and Shuai, B. (2023). Current Comprehensive Understanding of Denosumab (the RANKL Neutralizing Antibody) in the Treatment of Bone Metastasis of Malignant Tumors, Including Pharmacological Mechanism and Clinical Trials. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1133828"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/10781552241275943","article-title":"Role of Osteoclast Inhibitors in Prostate Cancer Bone Metastasis; a Narrative Review","volume":"31","author":"Wani","year":"2025","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Hayes, A.R., Brungs, D., and Pavlakis, N. (2018). Osteoclast Inhibitors to Prevent Bone Metastases in Men with High-Risk, Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191455"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrclinonc.2011.197","article-title":"Denosumab in Patients with Cancer\u2014A Surgical Strike against the Osteoclast","volume":"9","author":"Brown","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ctrv.2019.05.003","article-title":"Management of Bone Health in Solid Tumours: From Bisphosphonates to a Monoclonal Antibody","volume":"76","author":"Costa","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1369\/00221554231163638","article-title":"Inhibition of RANKL Expression in Osteocyte-like Differentiated Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment","volume":"71","author":"Noguchi","year":"2023","journal-title":"J. Histochem. Cytochem."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Wu, X., Li, F., Dang, L., Liang, C., Lu, A., and Zhang, G. (2020). RANKL\/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00076"},{"key":"ref_216","first-page":"18","article-title":"Research Progression in the Mechanism of Bone Metastasis and Bone-Targeted Drugs in Prostate Cancer","volume":"7","author":"Ahmad","year":"2024","journal-title":"Ann. Urol. Oncol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/bloodadvances.2020002378","article-title":"Denosumab Compared with Zoledronic Acid on PFS in Multiple Myeloma: Exploratory Results of an International Phase 3 Study","volume":"5","author":"Terpos","year":"2021","journal-title":"Blood Adv."},{"key":"ref_218","first-page":"838202","article-title":"Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies","volume":"2015","author":"Stenzl","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"113984","DOI":"10.1016\/j.ejca.2024.113984","article-title":"The RANKL Inhibitor Denosumab in Combination with Dual Checkpoint Inhibition Is Associated with Increased CXCL-13 Serum Concentrations","volume":"202","author":"Gutzmer","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1016\/j.jtho.2023.09.548","article-title":"P2.06-02 DEnosumab plus PD-1 Inhibitor for MAINtenance Therapy of Advanced KRAS-Mutant NSCLC\u2014A Prospective, Single-Arm, Phase II Study (DEMAIN)","volume":"18","author":"Li","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Bongiovanni, A., Foca, F., Menis, J., Stucci, S.L., Artioli, F., Guadalupi, V., Forcignan\u00f2, M.R., Fantini, M., Recine, F., and Mercatali, L. (2021). Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients with Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.697298"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Li, H.-S., Lei, S.-Y., Li, J.-L., Xing, P.-Y., Hao, X.-Z., Xu, F., Xu, H.-Y., and Wang, Y. (2022). Efficacy and Safety of Concomitant Immunotherapy and Denosumab in Patients with Advanced Non-Small Cell Lung Cancer Carrying Bone Metastases: A Retrospective Chart Review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.908436"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"107858","DOI":"10.1016\/j.lungcan.2024.107858","article-title":"Combination Therapy with Immune Checkpoint Inhibitors and Denosumab Improves Clinical Outcomes in Non-Small Cell Lung Cancer with Bone Metastases","volume":"193","author":"Asano","year":"2024","journal-title":"Lung Cancer"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00223-017-0353-5","article-title":"Bone-Targeted Therapies in Cancer-Induced Bone Disease","volume":"102","author":"Sousa","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_225","first-page":"CD003474","article-title":"Bisphosphonates and Other Bone Agents for Breast Cancer","volume":"10","author":"Wong","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ejca.2010.02.041","article-title":"Bisphosphonates and RANK Ligand Inhibitors for the Treatment and Prevention of Metastatic Bone Disease","volume":"46","author":"Coleman","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of Bone Metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.critrevonc.2011.05.009","article-title":"Could Targeting Bone Delay Cancer Progression? Potential Mechanisms of Action of Bisphosphonates","volume":"82","author":"Aft","year":"2012","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2011.09.003","article-title":"Direct and Indirect Anticancer Activity of Bisphosphonates: A Brief Review of Published Literature","volume":"38","author":"Gnant","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/jcm3020521","article-title":"Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives","volume":"3","author":"Beuzeboc","year":"2014","journal-title":"J. Clin. Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1158\/1538-7445.AM2024-4207","article-title":"Abstract 4207: Zoledronic Acid Reduces Quiescent Bone-Disseminated Human ER+ Breast Cancer Tumor Cell Burden and Estrogen-Responsiveness in a Pre-Clinical Model","volume":"84","author":"Cheng","year":"2024","journal-title":"Cancer Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/0929867033368529","article-title":"In Vitro and In Vivo Antitumor Effects of Bisphosphonates","volume":"10","author":"Clezardin","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1040-8428(11)70003-8","article-title":"The Backbone of Progress\u2014Preclinical Studies and Innovations with Zoledronic Acid","volume":"77","author":"Green","year":"2011","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-21892-7_3","article-title":"Bisphosphonates: Prevention of Bone Metastases in Breast Cancer","volume":"192","author":"Joerger","year":"2012","journal-title":"Prevention of Bone Metastases; Recent Results in Cancer Research"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00774-023-01408-z","article-title":"Differences between Zoledronic Acid and Denosumab for Breast Cancer Treatment","volume":"41","author":"Ishikawa","year":"2023","journal-title":"J. Bone Min. Metab."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4137\/CMRO.S3249","article-title":"Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer","volume":"2","author":"Iwamoto","year":"2010","journal-title":"Clin. Med. Rev. Oncol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.21608\/ejhm.2022.223620","article-title":"Efficacy and Safety of Denosumab Versus Zoledronic Acid in Suppressing Bone Metastases of Breast Cancer","volume":"87","author":"Gabr","year":"2022","journal-title":"Egypt. J. Hosp. Med."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Hamza, F.N., and Mohammad, K.S. (2024). Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments. Pharmaceuticals, 17.","DOI":"10.3390\/ph17121591"},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Tan, X., Jiang, Z., Wang, H., and Yuan, H. (2022). Immune Checkpoint Inhibitors in Osteosarcoma: A Hopeful and Challenging Future. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1031527"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Peng, L., Fang, H., Yang, X., and Zeng, X. (2022). Analysis of Combination Therapy of Immune Checkpoint Inhibitors in Osteosarcoma. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.847621"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12935-021-02407-8","article-title":"Combination Therapy with Immune Checkpoint Inhibitors (ICIs); a New Frontier","volume":"22","author":"Vafaei","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/s41388-020-1295-3","article-title":"The Premise of Personalized Immunotherapy for Cancer Dormancy","volume":"39","author":"Manjili","year":"2020","journal-title":"Oncogene"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1111\/febs.15626","article-title":"Targeting Dormant Tumor Cells to Prevent Cancer Recurrence","volume":"288","author":"Damen","year":"2021","journal-title":"FEBS J."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Sauer, S., Reed, D.R., Ihnat, M., Hurst, R.E., Warshawsky, D., and Barkan, D. (2021). Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.659963"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1038\/s41598-023-32554-z","article-title":"Targeting Myeloid-Derived Suppressor Cells in Combination with Tumor Cell Vaccination Predicts Anti-Tumor Immunity and Breast Cancer Dormancy: An in Silico Experiment","volume":"13","author":"Mehdizadeh","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.7150\/thno.92922","article-title":"Immunotherapeutic IL-6R and Targeting the MCT-1\/IL-6\/CXCL7\/PD-L1 Circuit Prevent Relapse and Metastasis of Triple-Negative Breast Cancer","volume":"14","author":"Haq","year":"2024","journal-title":"Theranostics"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Teleanu, R.I., Chircov, C., Grumezescu, A.M., and Teleanu, D.M. (2019). Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010084"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Olejarz, W., Kubiak-Tomaszewska, G., Chrzanowska, A., and Lorenc, T. (2020). Exosomes in Angiogenesis and Anti-Angiogenic Therapy in Cancers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165840"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic Signaling Pathways and Anti-Angiogenic Therapy for Cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Rajabi, M., and Mousa, S. (2017). The Role of Angiogenesis in Cancer Treatment. Biomedicines, 5.","DOI":"10.3390\/biomedicines5020034"},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Song, Y., Fu, Y., Xie, Q., Zhu, B., Wang, J., and Zhang, B. (2020). Anti-Angiogenic Agents in Combination with Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01956"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s12094-024-03432-5","article-title":"Advances in Tumor Vascular Growth Inhibition","volume":"26","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Mayasin, Y.P., Osinnikova, M.N., Kharisova, C.B., Kitaeva, K.V., Filin, I.Y., Gorodilova, A.V., Kutovoi, G.I., Solovyeva, V.V., Golubev, A.I., and Rizvanov, A.A. (2024). Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials. Cells, 13.","DOI":"10.20944\/preprints202410.1515.v1"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Lorusso, G., R\u00fcegg, C., and Kuonen, F. (2020). Targeting the Extra-Cellular Matrix\u2014Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01231"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"a006478","DOI":"10.1101\/cshperspect.a006478","article-title":"V Integrins in Angiogenesis and Cancer","volume":"1","author":"Weis","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"113745","DOI":"10.1016\/j.biopha.2022.113745","article-title":"Integrin-Mediated Cancer Progression as a Specific Target in Clinical Therapy","volume":"155","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Kobayashi, M., Sawada, K., and Kimura, T. (2017). Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review. Cancers, 9.","DOI":"10.3390\/cancers9070083"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"119504","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic Modulation and Understanding of HDAC Inhibitors in Cancer Therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Wang, H., Zhan, Z., Gan, L., and Bai, O. (2025). Mechanisms of HDACs in Cancer Development. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1529239"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1111\/febs.13746","article-title":"How Do Tumor Cells Respond to HDAC Inhibition?","volume":"283","author":"Newbold","year":"2016","journal-title":"FEBS J."},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Li, G., Tian, Y., and Zhu, W.-G. (2020). The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.576946"},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Wawruszak, A., Kalafut, J., Okon, E., Czapinski, J., Halasa, M., Przybyszewska, A., Miziak, P., Okla, K., Rivero-Muller, A., and Stepulak, A. (2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers, 11.","DOI":"10.3390\/cancers11020148"},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Eckschlager, T., Plch, J., Stiborova, M., and Hrabeta, J. (2017). Histone Deacetylase Inhibitors as Anticancer Drugs. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071414"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards Targeting of Shared Mechanisms of Cancer Metastasis and Therapy Resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1158\/1538-7445.AM2025-5098","article-title":"Abstract 5098: Targeting Fatty Acid Dependency in Hormone Receptor Positive HER2 Negative Drug Tolerant Persister Bone Metastases","volume":"85","author":"Goen","year":"2025","journal-title":"Cancer Res."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-Regulated Fatty Acid \u03b2-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"key":"ref_268","first-page":"108421","article-title":"Melanoma Persister Cells Are Tolerant to BRAF\/MEK Inhibitors Via ACOX1-Mediated Fatty Acid Oxidation","volume":"33","author":"Shen","year":"2020","journal-title":"SSRN J."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic Inhibition of Fatty Acid Oxidation Sensitizes Human Leukemia Cells to Apoptosis Induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1538-7445.AM2025-1544","article-title":"Abstract 1544: Fatty Acid Oxidation Inhibition with Anti-Cancer Agents Abrogated Tumor Growth in a Melanoma Cancer Model","volume":"85","author":"Park","year":"2025","journal-title":"Cancer Res."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1158\/1538-7445.AM2025-1697","article-title":"Abstract 1697: Chemotherapy Combined with Fatty Acid Oxidation Inhibition Completely Regressed Tumor Growth in a Pancreatic Cancer Model","volume":"85","author":"Woo","year":"2025","journal-title":"Cancer Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"177343","DOI":"10.1016\/j.ejphar.2025.177343","article-title":"Comprehensive Characterization of Fatty Acid Oxidation in Triple-Negative Breast Cancer: Focus on Biological Roles and Drug Modulation","volume":"991","author":"Liu","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s13402-025-01081-6","article-title":"Lipid Metabolism in Cancer Stem Cells: Reprogramming, Mechanisms, Crosstalk, and Therapeutic Approaches","volume":"48","author":"Lee","year":"2025","journal-title":"Cell Oncol."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Jinnah, A.H., Zacks, B.C., Gwam, C.U., and Kerr, B.A. (2018). Emerging and Established Models of Bone Metastasis. Cancers, 10.","DOI":"10.20944\/preprints201804.0295.v1"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Tamamouna, V., Pavlou, E., Neophytou, C.M., Papageorgis, P., and Costeas, P. (2022). Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213931"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-022-01503-5","article-title":"Gene Expression Predicts Dormant Metastatic Breast Cancer Cell Phenotype","volume":"24","author":"Ren","year":"2022","journal-title":"Breast Cancer Res."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"20230117","DOI":"10.1259\/bjr.20230117","article-title":"Advances in the Study of Biomarkers Related to Bone Metastasis in Breast Cancer","volume":"96","author":"Xu","year":"2023","journal-title":"Br. J. Radiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11893\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:23:33Z","timestamp":1765369413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":278,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262411893"],"URL":"https:\/\/doi.org\/10.3390\/ijms262411893","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}